Mark C Montag is a Bristol, Pennsylvania based male Ophthalmologist who is specialized in Ophthalmology. Active license number of Mark C Montag is MD420921 for Ophthalmology in Pennsylvania. Mark C Montag is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
Mark C Montag speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Ophthalmology
Credentials:
MD
Gender:
Male
Practice Address:
216 Mill Street, Bristol, Pennsylvania, 19007
Phone:
215-781-2020
Fax:
215-781-6794
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1043227358
NPI Enumeration Date:
01 Aug, 2006
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Mark C Montag are as mentioned below.
License Number
Specialization
State
Status
MD420921
Ophthalmology
Pennsylvania
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
216 Mill Street, Bristol, Pennsylvania
Zip:
19007
Phone Number:
215-781-2020
Fax Number:
215-781-6794
Patients can reach Mark C Montag at 216 Mill Street, Bristol, Pennsylvania or can call to book an appointment on 215-781-2020. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.